Wearable Artificial Organs Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Kidneys, Pancreas, Hearing Aids, and Others), By Application (Diabetes, End Stage Renal Disease, and Others), By End-user (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

The global wearable artificial organs market size was valued at USD 11.25 billion in 2024. The market is projected to grow from USD 13.85 billion in 2025 to USD 59.32 billion by 2032, exhibiting a CAGR of 17.45% during the forecast period.

Wearable artificial organs are devices used for the management of organ dysfunction. The wearable artificial organs include wearable kidneys, wearable pancreas, and wearable lungs, among others. These function normally as organs and allow the patient to be mobile and independent. An increase in the number of patients with chronic diseases such as kidney failure, heart failure, diabetes, and a rise in awareness toward improving the quality of life are contributing to the growth of the wearable artificial organs market.

• For instance, according to data published by the National Institute of Health in 2023, an estimated 37 million people in the U.S. are affected by chronic kidney diseases. Nearly 808,000 people in the country suffering from end-stage kidney disease in which 69% are on dialysis and 31% are with a kidney transplant.

Furthermore, an increase in the need for organ transplantation, lack of availability of donors, and unmet needs of patients with organ failure propel the growth of the wearable artificial organs market.

• According to data published in 2022 by the Australian Donation and Transplantation Activity Report, there was 8.0% reduction in organ donation in 2022 than 2021 with approximately 1800 people waiting for organ transplantation in Australia.

In addition, an increase in disposable income in both developed and emerging countries drives the growth of the wearable artificial organs market. This expansion is fueled by the desire to avoid high healthcare costs related to hospitals and medical equipment, as well as to reduce the mortality rate associated with chronic illnesses.

Impact of COVID-19 on the Wearable Artificial Organs Market

The wearable artificial organs market had a negative impact in 2020 due to the COVID-19 pandemic. During the pandemic, the focus of healthcare systems shifted toward managing the virus outbreak, leading to a reduction in the development and adoption of wearable artificial organs. Moreover, disruptions in the global supply chain, limitations in manufacturing capacities, and logistical challenges hindered the production and distribution of these devices, leading to a decrease in the utilization of products during a pandemic.

• For instance, in December 2022, according to data published by the National Institute of Health in the U.S., cochlear implantation utilization during the pandemic dropped by 15.0% in the mid-aged population and by 25.0% among the geriatric population. This hindered the market growth during COVID-19.

However, the market regained momentum as healthcare systems adapted to the new normal and demand for wearable artificial organs increased, indicating a rebound in the market's growth trajectory in 2022.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Key Chronic Diseases, By Key Countries/ Regions, 2022
• Advancements in Artificial Wearable Organs
• Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
• New Product Launches, By Key Players
• Impact of COVID-19 on the Market

Analysis by Product Type

Based on product type, the global market is segmented into kidneys, pancreas, and others. The kidneys segment recorded a considerable proportion of the global wearable artificial organs market in 2022. The growth was mainly attributed to the rise in chronic kidney diseases worldwide.

• According to data published by the International Society of Nephrology in 2022, chronic kidney disease is becoming a major health issue that has reached alarming levels, with an estimated 850.0 million people suffering from the condition worldwide.

Furthermore, the high cost of traditional dialysis procedures and the poor life quality of patients undergoing dialysis is estimated to drive segmental growth over the forecast period.

Regional Analysis

To gain extensive insights into the market, Download for Customization

North America dominated the wearable artificial organs market in 2022 and is projected to maintain its position over the forecast period. The growth is mainly attributed to the constantly growing demand for organ transplants in the U.S., due to which wearable artificial organs are widely adopted.

• According to the Health Resources & Services Administration’s organ donation statistics, in the U.S., approximately 103,327 men, women, and children were waiting for an organ transplant. (October 2023)

In addition, the robust growth of technology in the healthcare sector and increasing product launches, and the rising level of disposable income, are driving the growth of the market in North America.

Key Players Covered

The report includes the profiles of key players such as Wearable Artificial Organs, Inc., Medtronic, Asahi Kasei Corporation, Cochlear Ltd., AWAK Technologies, and others.

Key Industry Developments

• In September 2023, AWAK Technologies raised USD 20.0 million for a pivotal trial to launch a wearable dialysis device in the U.S. market.
• In August 2023, Cochlear Ltd. launched a new Osia System with Osia OSI300 Implant that allows patients to have a 3.0 Tesla MRI without requiring surgery. The Osia System is designed to improve hearing loss, mixed hearing loss, and single-sided sensorineural deafness (SSD) in people.
• In April 2023, Medtronic announced its U.S. Food and Drug Administration approval of the MiniMed 780G system. It is an artificial pancreas system that automatically adjusts and corrects blood-sugar levels every 5 minutes.